Faham Baig

What is your view on synthetic vape products? And is this an area that Altria could increase activity

The settlement payments in the quarter were down about 20% or $170 million. Anything that you would call out

there have been significant tariffs implemented on products imported from China, which would include the disposable vapes

your controllable costs in the final quarter was up around 13% which is a sharp movement

If you are able to successfully navigate that patent and are able to submit an SE application for that

how do you see the growth of nicotine pouches in 2025 and particularly the competitive dynamics

as we approach the five-year mark since since the launch of ICOS ILUMA. We look forward to the next evolution, what technical or functional do you see could could further improve consumer can conve...

the the currency guidance for the year was significantly better than the three estimates. Could you maybe share the key drivers

when do you expect this, process to potentially conclude? We or could you consider launching the product ahead of an approval It seems like some of your peers are

the gross margin gap between combustibles and and smoke free narrowed

if you could please remind us your FX hedge rates for for the year, both euro, Japanese yen

The net interest cost guidance for the year would be helpful, please

Are you in a position to potentially share what the MSA data highlights is the growth rate for ZYN

I just wanted to get your views on the recent movements at the CTP and how that impacts the timing of ILUMA